BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/20/2026 2:04:44 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 124080
Country Türkiye
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Review
Article Title Liver transplantation for intrahepatic cholangiocarcinoma: From contraindication to biology-driven selection
Manuscript Source Unsolicited Manuscript
All Author List Sami Akbulut and Sezai Yilmaz
ORCID
Author(s) ORCID Number
Sami Akbulut http://orcid.org/0000-0002-6864-7711
Sezai Yilmaz http://orcid.org/0000-0002-8044-0297
Funding Agency and Grant Number
Corresponding Author Sami Akbulut, FACS, MD, PhD, Professor, Department of Surgery and Liver Transplantation, Inonu University Faculty of Medicine, Elazig Yolu 10 Kilometers, Malatya 44280, Türkiye. akbulutsami@gmail.com
Key Words Intrahepatic cholangiocarcinoma; Liver transplantation; Transplant oncology; Patient selection; Neoadjuvant therapy; Tumor biology; Recurrence
Core Tip Liver transplantation (LT) should not be regarded as a routine treatment for intrahepatic cholangiocarcinoma, but as a highly selective option for carefully chosen patients. The most established evidence concerns cirrhotic patients with very early solitary tumors, whereas LT for selected patients with unresectable, liver-limited disease controlled after neoadjuvant therapy remains promising but investigational. In both settings, appropriate candidate selection requires durable disease stability, accurate staging, histological confirmation when feasible, and reliable exclusion of nodal and extrahepatic spread. Multidisciplinary assessment is essential, and LT should be considered only within strict selection protocols rather than as an alternative to resection in patients with safely resectable disease.
Publish Date 2026-11-20 02:04
Citation

Akbulut S, Yilmaz S. Liver transplantation for intrahepatic cholangiocarcinoma: From contraindication to biology-driven selection. World J Gastroenterol 2027; 33(3): 124080

URL https://www.wjgnet.com/1007-9327/full/v33/i3/124080.htm
DOI https://doi.org/10.3748/wjg.124080
Full Article (PDF) WJG-33-124080-with-cover.pdf